查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403348

心血管設備的全球市場預測（~2030 年）：按設備類型、應用、最終用戶和地區進行分析

Cardiovascular Devices Market Forecasts to 2030 - Global Analysis By Device Type, Application (Coronary Artery Disease, Heart Failure, Cardiac Arrhythmia and Other Applications), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年全球心血管器材市場規模為656.6億美元，預計2030年將達1,271.5億美元，預測期內複合年成長率為9.9%。

循環系統設備是用於診斷、治療和監測疾病和循環系統的醫療設備。它透過治療多種心血管疾病，包括心律不整、冠狀動脈疾病和心臟衰竭，在醫學上發揮重要作用。例如心律調節器、心臟去顫器、診斷成像設備、監測系統和導管。這些設備的重要性源自於它們提供有效治療方法、促進準確診斷和改善患者治療效果的能力。

根據世界衛生組織 (WHO) 的數據，大約 75% 與心血管疾病相關的死亡發生在低收入和中等收入國家。

心血管疾病盛行率上升

心臟衰竭、心律不整和冠狀動脈疾病 (CADD) 等心血管疾病 (CVD) 盛行率的上升是由多種因素造成的，包括久坐的生活方式、不健康的飲食、吸煙和高齡化。日益增加的疾病負擔增加了對創新心血管設備和技術的需求。置入式除顫器（ICD）、起搏器、藥物釋放型支架和心臟監測設備等設備在各種心血管疾病的診斷、治療和管理中發揮著至關重要的作用。這些先進技術有助於改善患者預後、降低死亡率並提高患者的整體生活品質。因此，對市場拓展的需求日益增加。

研究和開發活動的障礙增加

加強監管、更嚴格的安全標準以及大規模臨床試驗的需求顯著增加了研發成本和時間。這些障礙對小型企業和新興企業影響尤其嚴重，限制了他們進入市場和創新的能力。現有公司也面臨需要大量投資研發的障礙。這些高昂的研發障礙阻礙了新心血管設備的及時推出，阻礙了創新和市場成長。

遠端醫療和遠端監控

遠端醫療和遠端監控透過即時遠端監控生命徵象、心率和其他相關資料，促進持續的患者護理。對於心血管患者來說，它提供了家庭監測的便利性、減少了醫院就診次數並改善了獲得護理的機會。先進的穿戴式設備、行動應用程式和連網型平台使醫療保健專業人員能夠遠端評估患者狀況、及時採取干涉措施並提供個人化護理，最終幫助患者改善治療結果。遠端醫療和遠端監測在循環系統中的整合也將為創新鋪平道路，並促進開發更先進、方便用戶使用且有效的循環系統設備，專為遠端監測和遠端醫療應用而設計。

嚴格規定

不斷變化和嚴格的監管要求可能會導致核准流程更長、合規成本更高以及引入新設備的障礙增加。這些法規可能會抑制創新和市場進入，特別是對於資源有限、難以應對複雜監管環境的中小型企業。此外，監管變化和不確定性可能會擾亂現有的市場策略和投資，影響產品開發時間表和市場競爭力。

COVID-19 的影響

COVID-19 的疫情以各種方式對心血管設備市場產生了重大影響。最初，重點轉向控制大流行，由於醫療保健資源的重新分配和患者不願意接受非緊急治療，導致心血管疾病的擇期手術和診斷減少。供應鏈中斷和製造限制也影響了設備的可用性。然而，疫情加速了遠端醫療和遠端監控解決方案的採用，並刺激了心血管護理數位健康領域的創新。隨著疫苗接種率的提高和衛生系統適應新常態，選擇性手術逐漸恢復。

診斷和監測設備領域預計將在預測期內成為最大的領域

由於旨在檢測、監測和評估心血管疾病的先進技術，診斷和監測設備領域預計將佔據最大佔有率。這些設備可以即時監測心律、血壓和其他生命徵象，有助於及早發現異常情況並促進持續的患者照護。此外，這些設備在各種心血管疾病的診斷中發揮著至關重要的作用，為醫療保健專業人員提供了準確評估、個人化治療策略和改善患者治療結果的關鍵資料，最終有助於更好地管理和護理心臟病。

預計冠狀動脈疾病（CAD）領域在預測期內複合年成長率最高。

冠狀動脈疾病（CAD）領域預計在預測期內將出現良好的成長。冠狀動脈疾病 (CAD) 是指向心臟供應富氧血液的冠狀動脈變窄或阻塞。這些裝置有助於恢復心臟的血液流動、緩解症狀並降低心臟病發作的風險。 CAD專用設備支援經皮冠狀動脈介入（PCI）和冠狀動脈繞道手術手術（CABG）介入，改善這種常見心血管疾病的管理，改善患者的心臟健康和生活品質，並發揮至關重要的改善作用。

比最大的地區

在估計期間，亞太地區佔據最大的市場佔有率。亞太地區擁有多元化的醫療技術，主要集中在中國、印度和日本等國家治療心臟相關疾病。這個快速成長的市場的特點是心律管理設備、支架、診斷工具等方面的進步。此外，心血管疾病發生率的增加、醫療基礎設施的改善以及創新醫療解決方案的持續採用等因素也促進了市場的擴張。由於技術創新的整合和醫療意識的不斷提高，亞太地區對心血管設備的需求正在激增。

複合年成長率最高的地區：

以美國和加拿大為主要貢獻者的北美地區由於其強勁和成熟的形勢，預計在預測期內將實現盈利成長。該市場以其先進的醫療技術而聞名，包括各種心血管設備，包括起搏器、心臟去顫器、支架和成像工具。此外，高額醫療支出、先進的醫療基礎設施和龐大的患者群等因素正在推動市場成長。微創手術的創新加上對研究和開發的重視，有助於該地區在尖端心血管技術方面處於領先地位，並創造一個專注於改善患者治療結果的競爭市場環境。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球心血管設備市場：按設備類型

  • 診斷/監測裝置
    • 遠端心臟監測
    • 心電圖（ECG）
  • 治療/手術設備
    • 心臟輔助裝置
    • 導管
    • 心率管理裝置
    • 接枝
    • 支架
    • 心臟瓣膜
  • 其他設備類型

第6章全球心血管設備市場：依應用分類

  • 冠狀動脈疾病（CAD）
  • 心臟衰竭
  • 心律不整
  • 其他用途

第7章全球心血管設備市場：依最終用戶分類

  • 專科診所
  • 醫院
  • 心臟中心
  • 門診外科中心

第8章全球心血管設備市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Abbott
  • Cardinal Health
  • Boston Scientific Corporation
  • General Electric（GE Healthcare）
  • Medtronic
  • WL Gore & Associates, Inc.
  • Biotronik
  • Canon Medical Systems Corporation
  • Siemens Healthcare Gmbh
  • Edwards Lifesciences Corporation
  • Livanova PLC
  • B. Braun Melsungen AG
  • Johnson & Johnson Services, Inc.
  • Terumo Cardiovascular Systems Corporation
  • Philips Healthcare
  • Microport Scientific Corporation
  • Lepu Medical Technology（Beijing）Co Ltd
  • Occlutech
  • Getinge AB
  • Atricure, Inc
簡介目錄
Product Code: SMRC24573

According to Stratistics MRC, the Global Cardiovascular Devices Market is accounted for $65.66 billion in 2023 and is expected to reach $127.15 billion by 2030 growing at a CAGR of 9.9% during the forecast period. Cardiology devices are medical equipment intended to diagnose, treat, and monitor diseases and cardiovascular systems. They play a vital role in healthcare by treating a range of cardiovascular disorders, including arrhythmias, coronary artery disease, and heart failure. Some of these devices are pacemakers, defibrillators, imaging equipment, monitoring systems, and catheters. Their importance derives from their capacity to provide effective treatment initiatives, facilitate precise diagnosis, and improve patient outcomes-all of which significantly raise standards for cardiac health and save lives.

According to the World Health Organization, around 75% of the cardiovascular diseases related deaths occur in low and middle income countries.

Market Dynamics:

Driver:

Rising prevalence of cardiovascular diseases

The rising prevalence of cardiovascular diseases (CVDs) such heart failure, arrhythmias, and coronary artery disease (CADD) is attributed to several factors, including sedentary lifestyles, unhealthy diets, tobacco use, and ageing populations. This escalating disease burden necessitates a greater demand for innovative cardiovascular devices and technologies. Devices such as implantable cardioverter-defibrillators (ICDs), pacemakers, drug-eluting stents, and cardiac monitoring devices play pivotal roles in diagnosing, treating, and managing various cardiovascular conditions. These advanced technologies aid in improving patient outcomes, reducing mortality rates, and enhancing the overall quality of life for affected individuals. Therefore, there is an increasing demand for market expansion.

Restraint:

Increasing barriers in R&D activities

Heightened regulatory scrutiny, demanding safety standards, and the necessity for extensive clinical trials significantly elevate R&D costs and timelines. These barriers disproportionately affect smaller companies and start-ups, limiting their ability to enter the market and innovate. Established players also encounter impediments, requiring substantial investments in R&D. These mounting hurdles in R&D hinder the timely introduction of novel cardiovascular devices, impeding innovation and market growth.

Opportunity:

Telemedicine and remote monitoring

Telemedicine and remote monitoring facilitate continuous patient care by enabling remote monitoring of vital signs, cardiac rhythms, and other relevant data in real-time. For cardiovascular patients, this offers the convenience of home-based monitoring, reducing hospital visits, and enhancing accessibility to healthcare. Advanced wearable devices, mobile apps, and connected platforms allow healthcare professionals to remotely assess patients' conditions, provide timely interventions, and offer personalised care, ultimately improving patient outcomes. The integration of telemedicine and remote monitoring in cardiovascular also opens avenues for innovation, driving the development of more sophisticated, user-friendly, and effective cardiovascular devices tailored for remote monitoring and telehealth applications.

Threat:

Stringent regulations

Evolving and stringent regulatory requirements can result in prolonged approval processes, increased compliance costs, and heightened barriers for new device introductions. These regulations may inhibit innovation and market entry, particularly for smaller companies with limited resources to navigate complex regulatory landscapes. Also, regulatory changes or uncertainties might disrupt existing market strategies and investments, impacting product development timelines and market competitiveness.

COVID-19 Impact

The COVID-19 pandemic significantly affected the cardiovascular device market in various ways. Initially, the focus shifted towards managing the pandemic, causing a decline in elective procedures and diagnostics for cardiovascular conditions due to healthcare resource reallocation and patient reluctance to seek non-emergency care. Supply chain disruptions and manufacturing constraints also impacted device availability. However, the pandemic accelerated the adoption of telemedicine and remote monitoring solutions, driving innovation in digital health for cardiovascular care. As vaccination rates increased and healthcare systems adapted to the new normal, there was a gradual rebound in elective procedures.

The Diagnostic and Monitoring Devices segment is expected to be the largest during the forecast period

The Diagnostic and Monitoring Devices segment is estimated to hold the largest share, due to the advanced technologies designed to detect, monitor, and assess cardiovascular conditions. They enable real-time monitoring of heart rhythms, blood pressure, and other vital signs, aiding in the early detection of abnormalities and facilitating continuous patient care. Additionally, these devices play a pivotal role in diagnosing various cardiovascular diseases, providing healthcare professionals with crucial data for accurate assessments, personalised treatment strategies, and improved patient outcomes, ultimately contributing to better management and care of cardiac

The Coronary Artery Disease (CAD) segment is expected to have the highest CAGR during the forecast period

The Coronary Artery Disease (CAD) segment is anticipated to have lucrative growth during the forecast period. Coronary artery disease (CAD) is a narrowing or blockage of your coronary arteries, which supply oxygen-rich blood to the heart. These devices help restore blood flow to the heart, alleviate symptoms, and reduce the risk of heart attacks. CAD-specific devices aid in interventions such as percutaneous coronary interventions (PCI) and coronary artery bypass grafting (CABG), playing a pivotal role in managing this prevalent cardiovascular condition and improving patients' cardiac health and quality of life.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period. It encompasses a diverse landscape of medical technologies focused on treating heart-related conditions across countries like China, India, Japan, and others. This rapidly growing market features advancements in cardiac rhythm management devices, stents, diagnostic tools, and more. Moreover, factors such as rising cardiovascular diseases, improving healthcare infrastructure, and increasing adoption of innovative medical solutions contribute to the market's expansion. With a blend of technological innovation and growing healthcare awareness, the Asia Pacific region is witnessing a surge in demand for cardiovascular devices.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, owing to its robust and mature landscape, encompassing the United States and Canada as key contributors. Known for its advanced medical technologies, this market hosts a wide array of cardiovascular devices, including pacemakers, defibrillators, stents, and imaging tools. Furthermore, factors such as high healthcare spending, sophisticated healthcare infrastructure, and a large patient pool drive market growth. Innovations in minimally invasive procedures, coupled with a strong emphasis on research and development, contribute to the region's leadership in cutting-edge cardiovascular technologies, fostering a competitive market environment with a focus on improving patient outcomes

Key players in the market:

Some of the key players in the Cardiovascular Devices Market include Abbott, Cardinal Health, Boston Scientific Corporation, General Electric (GE Healthcare), Medtronic, W. L. Gore & Associates, Inc., Biotronik, Canon Medical Systems Corporation, Siemens Healthcare GmbH., Edwards Lifesciences Corporation, LivaNova PLC, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., Terumo Cardiovascular Systems Corporation, Philips Healthcare, MicroPort Scientific Corporation, Lepu Medical Technology(Beijing)Co Ltd, Occlutech, Getinge AB and AtriCure, Inc.

Key Developments:

In October 2022, Medtronic plc received United States FDA approval for expanded labeling of a cardiac lead that taps into the heart's natural electrical system, giving patients needed therapy while avoiding complications sometimes associated with traditional pacing methods, such as cardiomyopathy.

In October 2022, Biosense Webster, Inc., part of Johnson & Johnson MedTech launched the HELIOSTAR Balloon Ablation Catheter in Europe. The HELIOSTAR Balloon Ablation Catheter is indicated for use in the catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria and, when used with a compatible multi-channel RF generator, for cardiac ablation.

Device Types Covered:

  • Diagnostic and Monitoring Devices
  • Therapeutic and Surgical Devices
  • Other Device Types

Applications Covered:

  • Coronary Artery Disease (CAD)
  • Heart Failure
  • Cardiac Arrhythmia
  • Other Applications

End Users Covered:

  • Specialty Clinics
  • Hospitals
  • Cardiac Centers
  • Centers Ambulatory Surgical

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cardiovascular Devices Market, By Device Type

  • 5.1 Introduction
  • 5.2 Diagnostic and Monitoring Devices
    • 5.2.1 Remote Cardiac Monitoring
    • 5.2.2 Electrocardiogram (ECG)
  • 5.3 Therapeutic and Surgical Devices
    • 5.3.1 Cardiac Assist Devices
    • 5.3.2 Catheters
    • 5.3.3 Cardiac Rhythm Management Devices
    • 5.3.4 Grafts
    • 5.3.5 Stents
    • 5.3.6 Heart Valves
  • 5.4 Other Device Types

6 Global Cardiovascular Devices Market, By Application

  • 6.1 Introduction
  • 6.2 Coronary Artery Disease (CAD)
  • 6.3 Heart Failure
  • 6.4 Cardiac Arrhythmia
  • 6.5 Other Applications

7 Global Cardiovascular Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Specialty Clinics
  • 7.3 Hospitals
  • 7.4 Cardiac Centers
  • 7.5 Centers Ambulatory Surgical

8 Global Cardiovascular Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest Of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest Of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest Of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest Of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations And Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott
  • 10.2 Cardinal Health
  • 10.3 Boston Scientific Corporation
  • 10.4 General Electric (GE Healthcare)
  • 10.5 Medtronic
  • 10.6 W. L. Gore & Associates, Inc.
  • 10.7 Biotronik
  • 10.8 Canon Medical Systems Corporation
  • 10.9 Siemens Healthcare Gmbh
  • 10.10 Edwards Lifesciences Corporation
  • 10.11 Livanova PLC
  • 10.12 B. Braun Melsungen AG
  • 10.13 Johnson & Johnson Services, Inc.
  • 10.14 Terumo Cardiovascular Systems Corporation
  • 10.15 Philips Healthcare
  • 10.16 Microport Scientific Corporation
  • 10.17 Lepu Medical Technology(Beijing)Co Ltd
  • 10.18 Occlutech
  • 10.19 Getinge AB
  • 10.20 Atricure, Inc

List Of Tables

  • Table 1 Global Cardiovascular Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 3 Global Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 4 Global Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 5 Global Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 6 Global Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 7 Global Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 8 Global Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 9 Global Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 10 Global Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 11 Global Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 12 Global Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 13 Global Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 14 Global Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 15 Global Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 16 Global Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 17 Global Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 18 Global Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 19 Global Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 20 Global Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 21 Global Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 22 Global Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 23 North America Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 25 North America Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 26 North America Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 27 North America Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 28 North America Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 29 North America Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 30 North America Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 31 North America Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 32 North America Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 33 North America Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 34 North America Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 35 North America Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 36 North America Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 37 North America Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 38 North America Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 39 North America Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 40 North America Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 41 North America Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 42 North America Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 43 North America Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 44 North America Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 45 Europe Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 47 Europe Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 48 Europe Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 49 Europe Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 50 Europe Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 51 Europe Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 52 Europe Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 53 Europe Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 54 Europe Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 55 Europe Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 56 Europe Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 57 Europe Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 58 Europe Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 59 Europe Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 60 Europe Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 61 Europe Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 62 Europe Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 63 Europe Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 64 Europe Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 65 Europe Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 66 Europe Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 67 Asia Pacific Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 69 Asia Pacific Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 70 Asia Pacific Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 71 Asia Pacific Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 72 Asia Pacific Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 73 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 74 Asia Pacific Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 75 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 76 Asia Pacific Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 77 Asia Pacific Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 78 Asia Pacific Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 79 Asia Pacific Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 80 Asia Pacific Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 81 Asia Pacific Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 82 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 83 Asia Pacific Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 84 Asia Pacific Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 85 Asia Pacific Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 86 Asia Pacific Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 87 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 88 Asia Pacific Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 89 South America Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 91 South America Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 92 South America Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 93 South America Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 94 South America Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 95 South America Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 96 South America Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 97 South America Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 98 South America Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 99 South America Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 100 South America Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 101 South America Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 102 South America Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 103 South America Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 104 South America Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 105 South America Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 106 South America Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 107 South America Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 108 South America Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 109 South America Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 110 South America Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 111 Middle East & Africa Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 113 Middle East & Africa Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 114 Middle East & Africa Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 115 Middle East & Africa Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 116 Middle East & Africa Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 117 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 118 Middle East & Africa Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 119 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 120 Middle East & Africa Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 121 Middle East & Africa Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 122 Middle East & Africa Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 123 Middle East & Africa Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 124 Middle East & Africa Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 125 Middle East & Africa Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 126 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 127 Middle East & Africa Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 128 Middle East & Africa Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 129 Middle East & Africa Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 130 Middle East & Africa Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 131 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 132 Middle East & Africa Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)